164 related articles for article (PubMed ID: 28369705)
1. Variant histology nodular lymphocyte predominant Hodgkin lymphoma - a route to transformation?
Szychot E; Shankar A; Haider A; Ramsay A
Br J Haematol; 2018 May; 181(3):403-406. PubMed ID: 28369705
[No Abstract] [Full Text] [Related]
2. Familial nodular lymphocyte predominant Hodgkin lymphoma: Successful treatment with CHOP plus rituximab.
Unal A; Sari I; Deniz K; Ozkan M; Kontas O; Eser B; Cetin M
Leuk Lymphoma; 2005 Nov; 46(11):1613-7. PubMed ID: 16236615
[TBL] [Abstract][Full Text] [Related]
3. Mycobacterium avium intracellulare infection coexistent with nodular lymphocyte predominant Hodgkin lymphoma involving the lung.
Gupta S; Cogbill CH; Gheorghe G; Rao AR; Kumar S; Havens PL; Camitta BM; Warwick AB
J Pediatr Hematol Oncol; 2011 Apr; 33(3):e127-31. PubMed ID: 21399527
[TBL] [Abstract][Full Text] [Related]
4. [A combined therapy program for children with lymphogranulomatosis].
Poliakov VE; Ankudinov VA; Tsygankin VI; Makhonova LA
Pediatriia; 1984 Feb; (2):34-7. PubMed ID: 6546987
[No Abstract] [Full Text] [Related]
5. Nodular sclerosing Hodgkin disease presenting as a sternal mass.
Priola SM; Priola AM; Cataldi A; Fava C
Br J Haematol; 2006 Dec; 135(5):594. PubMed ID: 17107345
[No Abstract] [Full Text] [Related]
6. Rituximab-ABV(D) for patients with Nodular lymphocyte predominant Hodgkin lymphoma ineligible for radiation therapy.
Garciaz S; Harel S; Amorim S; Bouabdallah R; Thieblemont C; Brice P
Br J Haematol; 2016 Nov; 175(4):735-737. PubMed ID: 26685097
[No Abstract] [Full Text] [Related]
7. Breast involvement in nodular lymphocyte predominant type Hodgkin lymphoma in childhood.
Aksu G; Inan N; Corapcioglu F; Tugay M; Anik YA
Pediatr Hematol Oncol; 2008 Mar; 25(2):159-61. PubMed ID: 18363184
[No Abstract] [Full Text] [Related]
8. Nodular lymphocyte predominant Hodgkin lymphoma with clusters of LP Cells, acute inflammation, and fibrosis: a syncytial variant.
Drakos E; Rassidakis GZ; Leventaki V; Cotta CV; Vega F; Medeiros LJ
Am J Surg Pathol; 2009 Nov; 33(11):1725-31. PubMed ID: 19730363
[TBL] [Abstract][Full Text] [Related]
9. Hodgkin lymphoma with cutaneous involvement.
Hsia CC; Howson-Jan K; Rizkalla KS
Dermatol Online J; 2009 May; 15(5):5. PubMed ID: 19624983
[TBL] [Abstract][Full Text] [Related]
10. [Late recurrences in Hodgkin's disease: description of a case after 14 yr of continuous remission].
Vila S; Zerga M; Villegas A; Somoza N
Sangre (Barc); 1991 Apr; 36(2):163-5. PubMed ID: 1866655
[No Abstract] [Full Text] [Related]
11. A chemotherapy only therapeutic approach to pediatric Hodgkin lymphoma: AHOPCA LH 1999.
Castellanos EM; Barrantes JC; Báez LF; Gamboa Y; Peña A; Alabi S; Bonilla M; Wang H; Metzger ML; de Alarcón PA
Pediatr Blood Cancer; 2014 Jun; 61(6):997-1002. PubMed ID: 24347509
[TBL] [Abstract][Full Text] [Related]
12. Composite splenic marginal zone lymphoma and classic Hodgkin lymphoma -- an unusual combination.
Elmahy H; Hawley I; Beard J
Int J Lab Hematol; 2007 Dec; 29(6):461-3. PubMed ID: 17988302
[TBL] [Abstract][Full Text] [Related]
13. Hematuria--a rare presentation of Hodgkin lymphoma.
Dembla V; Walker BN; Elkins SL; Files JC
Clin Adv Hematol Oncol; 2011 Oct; 9(10):788-90; discussion 791-2. PubMed ID: 22252582
[No Abstract] [Full Text] [Related]
14. Nodular lymphocyte predominant Hodgkin lymphoma: diagnostic pearls and pitfalls.
Smith LB
Arch Pathol Lab Med; 2010 Oct; 134(10):1434-9. PubMed ID: 20923296
[TBL] [Abstract][Full Text] [Related]
15. Treatment outcome after low intensity chemotherapy [CVP] in children and adolescents with early stage nodular lymphocyte predominant Hodgkin's lymphoma - an Anglo-French collaborative report.
Shankar A; Hall GW; Gorde-Grosjean S; Hasenclever D; Leblanc T; Hayward J; Lambilliotte A; Daw S; Perel Y; McCarthy K; Lejars O; Coulomb A; Oberlin WO; Wallace WH; Landman-Parker J
Eur J Cancer; 2012 Jul; 48(11):1700-6. PubMed ID: 22093944
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary lymphocyte-rich classical Hodgkin lymphoma with early response to ABVD therapy.
Honda A; Nakamura F; Nannya Y; Shintani Y; Fukayama M; Ichikawa M; Kurokawa M
Ann Hematol; 2014 Jun; 93(6):1073-4. PubMed ID: 24173088
[No Abstract] [Full Text] [Related]
17. [Resistance to first line chemotherapy treatment in a patient diagnosed of nodular lymphocyte-predominant Hodgkin's lymphoma identified by 18F-FDG PET/CT: diagnostic and therapeutic implications].
Banzo J; Ubieto MA; Giraldo P; Razola P; Prats E; Tardin L; Santapau A; Parra A; Rambalde EF; Velilla J
Rev Esp Med Nucl Imagen Mol; 2012; 31(2):89-92. PubMed ID: 21620527
[TBL] [Abstract][Full Text] [Related]
18. Concomitant classic Hodgkin lymphoma and schistosomiasis.
Wong WJ; Ruhangaza D; Manirakiza A; Omondi J; Mugabe MC; Isabelle I; Morgan EA; Aster JC
Am J Hematol; 2019 Jul; 94(7):840-841. PubMed ID: 30328130
[No Abstract] [Full Text] [Related]
19. The unique entity of nodular lymphocyte-predominant Hodgkin lymphoma: current approaches to diagnosis and management.
Hawkes EA; Wotherspoon A; Cunningham D
Leuk Lymphoma; 2012 Mar; 53(3):354-61. PubMed ID: 21812538
[TBL] [Abstract][Full Text] [Related]
20. Treatment of advanced stage Hodgkin lymphoma--it's all about risk-benefit.
Phipps C; Lee YS; Hwang W
Br J Haematol; 2012 Oct; 159(1):113-5. PubMed ID: 22823109
[No Abstract] [Full Text] [Related]
[Next] [New Search]
